增强了用于肝细胞癌治疗的 podophyllotoxin 的递送,使用聚合体作为抗癌递送平台
Parvaneh Peyvand1, Zahra Vaezi2, Mohsen Sharifi3
1Department of Nanobiotechnology, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran.
Journal of biomaterials science. Polymer edition
|June 19, 2025
概括
这项研究开发了mPEG-PCL纳米粒子,以改善用于癌症治疗的 podophyllotoxin (PPT) 输送. 纳米粒子有效地将PPT传递给癌细胞,增强其抗癌活性,并显示出药物开发的前景.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 癌症治疗方法 癌症治疗方法
背景情况:
- 波多菲洛毒素 (PPT) 是一种有前途的抗癌化合物,但具有较差的溶解性和生物可用性.
- 有效的药物输送系统对于提高PPT的治疗效果至关重要.
研究的目的:
- 开发和描述mPEG-PCL纳米颗粒,用于向HepG2癌细胞输送 podophyllotoxin (PPT).
- 为了在体外评估装载PPT的纳米颗粒的疗效.
主要方法:
- 使用各种分析技术 (UV-Vis,FTIR,HNMR,XRD,FESEM) 合成和表征mPEG-PCL共聚合物.
- 通过纳米沉来制备和优化带有PPT的mPEG-PCL纳米粒子.
- 评估纳米粒子的物理化学性质,药物负载,释放动力学,细胞吸收和体外细胞毒性.
主要成果:
- 优化的mPEG-PCL纳米粒子表现出有利的特征 (大小,表面电荷,均的球形形态).
- 实现了PPT的高封装和加载效率 (分别为79.89%和10.15%).
- 与免费PPT相比,装载PPT的纳米颗粒显示了持续的药物释放,增强的细胞吸收和增加的体外细胞毒性.
结论:
- mPEG-PCL纳米颗粒代表了一个可行的和有效的podophyllotoxin的输送系统.
- 这种纳米颗粒配方显示出通过控制药物释放和增强疗效来改善基于PPT的癌症治疗的显著潜力.
更多相关视频
09:56Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
Published on: August 2, 2016
15.0K
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
11.0K
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
141
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
141
Site-Targeted Drug Delivery Systems: Polymeric Carriers
127
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
127
